Paradigm co-founder Matt Huang’s testimony: SBF once stated that Alameda Research does not have preferential treatment at FTX

Odaily News Paradigm co-founder Matt Huang testified in court on Thursday regarding the SBF case and described the process of Paradigm investing a total of approximately US$278 million in FTX twice. Matt Huang said that he was excited by FTX’s rapid early market share growth, but he was concerned about FTX’s lack of formal governance structure or even board of directors, and SBF had told him that Alameda Research did not have preferential treatment at FTX. In addition, Matt Huang also mentioned that Paradigm’s investment in FTX has been accrued to zero. (The Block)